GRACE :: Lung Cancer

molecular testing

Denise Brock

Lung Cancer Video Library – Molecular Testing At Initial Diagnosis Of Advanced Non-Small Cell Lung Cancer (NSCLC) Current Standards

Share

 

GRACE Cancer Video Library - Lung

 

Dr. Stephen Liu

 

We are pleased to have Dr. Stephen Liu  bring us further 2017 updates for our 2017 Lung Cancer Video Library.  

Dr. Liu, a board-certified medical oncologist, specializes in lung cancer, cancers of the head and neck, and skin. Dr. Liu is a strong advocate of genomic testing to identify actionable mutations leading to the most effective, targeted therapies for personalized care. He is the recipient of many teaching and patient care awards. 

In this latest video, Dr. Liu discusses Current Standards – Molecular Testing At Initial Diagnosis Of Advanced Non-Small Cell Lung Cancer (NSCLC).


 

 

 

 

How Did You Like This Video?

Please feel free to offer comments and raise questions in our Discussion Forums.


 We would like to thank the following companies for their support of this program

 

                

 

 

                        

 

 
 

 

 


  


Denise Brock

Targeted Therapies in Lung Cancer Patient Forum 2016 – Evolving Landscape with Dr. Dara Eisner

Share

Presented by the

Global Resource for Advancing Cancer Education
in collaboration with
the University of Colorado
Cancer Center
 
On August 20, 2016, in collaboration with the University of Colorado Cancer Center, GRACE presented the Targeted Therapies in Lung Cancer Patient Forum in Aurora Colorado.  In this eighth video from the webcast series, GRACE presents the lunchtime keynote discussion: The Evolving Landscape of Molecular Testing in Lung Cancer: Who, How and When? featuring Dr. Dara Eisner.

Download the Agenda and Speaker Bios

(click for speaker slides)
The Evolving Landscape of Molecular Testing in Lung Cancer: Who, How and When?
 


How Did You Like This Video?

Please feel free to offer comments and raise questions in our Discussion Forums.

 

GRACE Video

The Lung Cancer Master Protocol/SWOG 1400 as a Clinical Trial for a New Era of Molecular Oncology

Share

LCAM 2015

 

Dr. Jack West reviews the Lung Cancer Master Protocol for second line treatment of patients with advanced squamous NSCLC, an “umbrella protocol” in which all patients undergo molecular testing and have treatment assigned by the results.

November is Lung Cancer Awareness Month. What are you grateful for?

Watch, read, and then share your own stories of empowerment in our online forum. Your story may inspire others.

Get more information about the Lung-MAP Trial.

How Did You Like This Video?

Check out more LCAM videos & posts here.


GRACE Video

Molecular Testing in Early Stage Non-Small Cell Lung Cancer

Share

Does it make sense to do molecular testing on early stage lung cancer patients? Dr. Taofeek Owonikoko of Emory University School of Medicine and the Winship Cancer Institute thinks it does in some settings. February 2014


GRACE Video

Is It Necessary for Early Stage Lung Cancer Patients to Get Molecular Testing for Their Tumors?

Share

If you were diagnosed with early stage lung cancer, should you receive molecular testing on your tumor in order to get targeted therapy? Dr. Joel Neal of Stanford University Medical Center discusses the reasons for and against it. February 2014.


Ask Us, Q&A
Lung/Thoracic Cancer Expert Content

Archives

Share

GRACE Cancer Video Library - Lung Cancer Videos

 

2015_Immunotherapy_Forum_Videos

 

2015 Acquired Resistance in Lung Cancer Patient Forum Videos

Share

Join the GRACE Faculty

Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog
Share

Subscribe to the GRACEcast Podcast on iTunes

Share

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

Share

ClinicalTrials.gov


Biomedical Learning Institute

peerview_institute_logo_243